SCHEMBL839250

SCHEMBL839250

FC(F)(F)NNc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
TDP1 Q9NUW8 4/20 0.55
CTSD P07339 1/20 0.55
MAPT P10636 4/20 0.43
CYP3A4 P08684 3/20 0.43
GAA P10253 2/20 0.43
ALOX12 P18054 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
KDM4E B2RXH2 1/20 0.43
HSD17B10 Q99714 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
TSHR P16473 4/20 0.39
PTGS2 P35354 3/20 0.39
ALOX15 P16050 1/20 0.39
PTGS1 P23219 1/20 0.39
SLC6A2 P23975 1/20 0.39
MAPK1 P28482 1/20 0.39
HTR2B P41595 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL2497266 0.97 ALDH1A1 (0.52) ALDH1A1TDP1CTSDMAPTCYP3A4
Bromide SCHEMBL28378200 0.97 ALDH1A1 (0.52) ALDH1A1TDP1CTSDMAPTCYP3A4
Oxalic Acid SCHEMBL28377528 0.89 GAA (0.48) ALDH1A1TDP1CTSDMAPTCYP3A4
SCHEMBL7408731 0.75 PTGS2 (0.41) ALDH1A1MAPTCYP3A4GAAALOX12
SCHEMBL5397882 0.74 TDP1 (0.55) ALDH1A1TDP1CTSDMAPTCYP3A4
Hydrazobenzene SCHEMBL51179 0.73 ALDH1A1 (1.00) ALDH1A1TDP1CTSDMAPTCYP3A4
SCHEMBL19737269 0.73 ALDH1A1 (1.00) ALDH1A1TDP1CTSDMAPTCYP3A4
SCHEMBL412378 0.72 ALDH1A1 (0.45) ALDH1A1TDP1CTSDMAPTCYP3A4
SCHEMBL9172014 0.72 ALDH1A1 (0.52) ALDH1A1TDP1CTSDMAPTCYP3A4
Fluoride SCHEMBL5178837 0.70 ALDH1A1 (0.43) ALDH1A1TDP1CTSDMAPTCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118852082-A Flavonol derivative containing hydrazide active fragment and application thereof 南京农业大学 2024-10-29 CN disclosed
CN-114634442-B Preparation method of tetrahydrocarbazolone compound 内蒙古民族大学 2023-10-13 CN disclosed
WO-2022040157-A1 BORON CONTAINING COMPOUNDS AND THEIR USES 5METIS, INC. (US) 2022-02-24 WO disclosed
CN-108586527-B Aryl phosphonate compound and preparation method thereof 郑州大学 2020-03-31 CN disclosed
CN-108586527-A Arylphosphonic acid ester type compound and preparation method thereof 郑州大学 2018-09-28 CN disclosed
EP-2268623-B9 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF AMBIT BIOSCIENCES CORP (US) 2018-02-28 EP disclosed
CN-107663161-A A kind of continuous stream synthesis technique of phenylhydrazine salt and substituted benzene hydrazonium salt 上海惠和化德生物科技有限公司 2018-02-06 CN disclosed
US-9730937-B2 RAF kinase modulator compounds and methods of use thereof AMBIT BIOSCIENCES CORPORATION (US) 2017-08-15 US disclosed
EP-3147281-A1 QUINAZOLINE DERIVATIVES AS RAF KINASE MODULATORS AND METHODS OF USE THEREOF Ambit Biosciences Corporation (US) 2017-03-29 EP disclosed
CN-106146484-A Quinazoline derivant is as RAF kinase modulator and their method and purposes 埃姆比特生物科学公司 2016-11-23 CN disclosed
US-20070049632-A1 Pyrazolones as inhibitors of 11B-hydroxysteroid dehydrogenase BANNER BRUCE L 2007-03-01 US disclosed
CN-1865248-A Imidazole-4-carboxamide derivatives, preparation and use thereof for treatment of obesity BAYER PHARMACEUTICALS CORP (US) 2006-11-22 CN disclosed
US-20060135712-A1 Ethylened polymer and molded object obtained therefrom MITSUI CHEMICALS, INC. (JP) 2006-06-22 US disclosed
US-20060106013-A1 PI3-kinases BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2006-05-18 US disclosed
CN-1642879-A Process for preparing diaryl compounds SUMITOMO CHEMICAL CO (JP) 2005-07-20 CN disclosed
CN-1599724-A Imidazole-4-carboxamide derivatives, their preparation and use in the treatment of obesity BAYER PHARMACEUTICALS CORPORAT (US) 2005-03-23 CN disclosed
CN-1043766-C Indole derivative and preparation and pharmaceutical using of same TORAY INDUSTRIES (JP) 1999-06-23 CN disclosed
CN-1092425-A Indole derivatives, its manufacture method and medicinal use thereof TORAY INDUSTRIES (JP) 1994-09-21 CN disclosed
US-5051417-A Indolythiadiazines for treating heart failure LES LABORATOIRES BEECHAM S.A. (FR) 1991-09-24 US disclosed
EP-0351213-A2 2-Indolones substituted in 5 by a cyclic hydrazide radical, their preparation and their use in cardio-active medicaments LES LABORATOIRES BEECHAM S.A. (FR) 1990-01-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049632-A1 Pyrazolones as inhibitors of 11B-hydroxysteroid dehydrogenase HSD17B1, HSD17B2, HSD3B2 ALDH1A1 105/4885TDP1 1844/4885CTSD 3617/4885
US-20060106013-A1 PI3-kinases PIK3C3, PIK3CB, PIK3CD ALDH1A1 1935/4885TDP1 3518/4885CTSD 1952/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.